Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit
Company to also share progress with cell-based virotherapy platforms for advanced solid tumors ...
Source: marketscreener.com